Arrotek

Expanding Capacity with a New Class 7 Cleanroom at Our Irish Facility

Construction work has finished on a new Class 7 cleanroom at our purpose-built medical device design and manufacturing facility in Sligo, Ireland. At 300 sqm, this new cleanroom will be our largest in Europe and will enhance our capabilities. In addition to the new 300 sqm cleanroom, we have also built a 90 sqm packing Expanding Capacity with a New Class 7 Cleanroom at Our Irish Facility

A New Website and Enhanced Design Services to Support Our Customers

Earlier this month we launched our new website as part of the exciting evolution of the Arrotek brand. That evolution includes enhancing our design service offering for customers and bringing our brands Needletech and Concert Medical under the Arrotek brand name, reflecting the company’s expanding global footprint. The new website has a modern design that A New Website and Enhanced Design Services to Support Our Customers

Inspiring Inclusion at Arrotek on International Women’s Day

Tomorrow is International Women’s Day and the theme this year represents an important priority for us at Arrotek. That theme is “Inspire Inclusion” where the aim is to “understand and value women’s inclusion” and “forge a more inclusive world for women”. At Arrotek, we are conscious of the gender disparity that continues to exist in Inspiring Inclusion at Arrotek on International Women’s Day

Medical Device Design Validation Explained

Medical device design validation is an essential part of the product development process. Effective and efficient design validation can help ensure the smooth running of your project. It is also essential for patient and user safety, and it is a key requirement to get regulatory approval for your new medical device product. There is sometimes Medical Device Design Validation Explained

Arrotek Co-Founder Mark Pugh Named CEO of Theragenics Corporation

Arrotek’s Co-Founder, Mark Pugh, has been appointed as CEO of Theragenics Corporation, the US-based parent company of Arrotek. The Theragenics Corporation includes the brands Theragenics, Arrotek, Galt, and NeedleTech. It specialises in the supply, design, and manufacture of minimally invasive medical devices. Mr Pugh succeeds Frank Tarallo who retired at the end of 2023 following Arrotek Co-Founder Mark Pugh Named CEO of Theragenics Corporation

Designing Medical Device Braiding – Achieving Optimum Levels of Performance

Braiding is an essential component in many minimally invasive medical devices, including some of the most advanced interventional and diagnostic catheters. Medical device braiding is also used in positioning devices, occlusion devices, expandable delivery sheaths, and more. As it’s an essential component, designing medical device braiding is an important part of the new product development Designing Medical Device Braiding – Achieving Optimum Levels of Performance

Arrotek will be exhibiting at MD&M West

The Arrotek Medical team are looking forward to exhibiting at the upcoming MD&M west show in Anaheim Convention Center, Anaheim, CA, USA from 6 – 8 February 2024. Drop by booth #2711 to meet with one of our technical sales team to discuss your next medical device design and manufacturing project.

New Cleanrooms Opened at Our US Facility

To enhance the level of service we offer our clients, we have opened two new cleanrooms in our US facility – a Class 7 cleanroom and a Class 6 cleanroom. Find out more on the arrotek.com website – click here.

Arrotek Opens New Cleanrooms in US Facility

We have opened new cleanrooms in our medical device design and manufacturing facility in the US. Our base in North Attleboro, Massachusetts now has two new cleanroom facilities, extending and enhancing the service we offer to customers. The new cleanrooms in our US facility include: Bill Fralick, Director of Quality Assurance and Regulatory Affairs at Arrotek Opens New Cleanrooms in US Facility

Designing Transcatheter Aortic Valve Implantation (TAVI) Systems

Transcatheter aortic valve implantation (TAVI) systems are commonly used in procedures to treat aortic stenosis by improving the flow of blood in the heart. This can have a transformative impact on patients, especially as TAVI procedures are minimally invasive and significantly reduce the need for open heart surgery. TAVI procedures are also referred to as Designing Transcatheter Aortic Valve Implantation (TAVI) Systems